葡萄膜巩膜途径降眼压机制治疗青光眼的研究进展  

Advances in the study of the mechanism of uveoscleral pathway to reduce intraocular pressure in treatment of glaucoma

作　　者：张勇[1] 朱小敏 谢琳 Yong Zhang;Xiao-Min Zhu;Lin Xie(Department of Ophthalmology, the 82 nd Hospital of People's Liberation Army of China, Huaian 233000, Jiangsu Province, China;Department of Ophthalmology, the Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China)

机构地区：[1]中国人民解放军第八二医院眼科,中国江苏省淮安市233000 [2]重庆医科大学附属第三医院眼科,中国重庆市401120

出　　处：《国际眼科杂志》2019年第7期1131-1133,共3页International Eye Science

基　　金：国家自然科学基金项目(No.81670860);重庆市自然科学基金(No.cstc2018jcyjAX0034)~~

摘　　要：房水排出障碍导致的眼压升高是引起青光眼发病的主要原因,而降眼压仍是目前青光眼治疗的主要方法。房水外流主要通过传统的小梁网途径和非传统的葡萄膜巩膜途径,通过非压力依赖性的葡萄膜巩膜途径降低眼压以治疗青光眼越来越受到重视。本文综述了应用药物和手术从葡萄膜巩膜途径降眼压机制治疗青光眼的研究进展。The elevation of intraocular pressure (IOP) caused by aqueous humor obstruction is the main cause of glaucoma, and lowering IOP is still the main method of glaucoma treatment. Aqueous humor drainage is mainly through the traditional trabecular route and non-traditional uveoscleral route. More and more attention has been paid to reducing IOP through a non-pressure-dependent uveoscleral route in treatment of glaucoma. This article reviews the advances in treatment of glaucoma by using drugs and surgery through the uveoscleral route to reduce IOP.

关 键 词：青光眼 眼压 葡萄膜巩膜途径 

分 类 号：R775[医药卫生—眼科]